CDK1 and acute myeloid leukemia: High expression levels are detected in some AML cases who did not respond to treatment, and increased nuclear CDK1 levels are associated with worse outcomes and lower complete remission (CR).Moreover, AML cases with relapse of disease have enhanced levels of CDK1 transcription [9].